Tempest Therapeutics, Inc. SEC filings TPST
Tempest Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 1, 2013. Its latest annual report, Form ARS, was filed on Nov 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Nov 2, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Dec 31, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 19, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 22, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Apr 1, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 29, 2022 | Dec 31, 2021 |
| 10-K/A | Amended annual report | Apr 29, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 29, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 11, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Apr 1, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 15, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 2, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 26, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 16, 2015 | Dec 31, 2014 |
| ARS | Annual report to shareholders | May 7, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Feb 27, 2014 | Dec 31, 2013 |
| ARS | Annual report to shareholders | Apr 29, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Feb 25, 2013 | Dec 31, 2012 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TPST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1544227
- Former names
- Millendo Therapeutics, Inc. (until Jul 1, 2021); OvaScience, Inc. (until Dec 6, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.